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Many new viruses have been discovered recently, thanks in part to the advent of next-
generation sequencing technologies. Among the Parvoviridae, three novel members of
the genus Amdoparvovirus have been described in the last 4 years, expanding this
genus that had contained a single species since its discovery, Aleutian mink disease
virus. The increasing number of molecular and epidemiological studies on these viruses
around the world also highlights the growing interest in this genus. Some aspects of
amdoparvoviruses have been well characterized, however, many other aspects still need
to be elucidated and the most recent reviews on this topic are outdated. We provide here
an up-to-date overview of what is known and what still needs to be investigated about
these scientifically and clinically relevant animal viruses.
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ALEUTIAN MINK DISEASE VIRUS (AMDV) DISCOVERY AND
INITIAL CHARACTERIZATIONS
Aleutian disease was originally observed in the USA during the late 1940s in Aleutian mink,
a novel gunmetal gray variety similar in color to the Aleutian foxes (Gorham et al., 1965).
The disease, also called plasmacytosis (a high number of plasma cells in tissues or exudates),
was therefore already known to farmers for some years when it was oﬃcially reported for
the ﬁrst time in 1956 as a disease of unknown origin (Hartsough and Gorham, 1956). As
it initially appeared to be restricted to Aleutian mink it was mistaken for a genetic disorder
and often went unnoticed, masked by other outbreaks predominant at that time such as
distemper and botulism (Gorham et al., 1965). After devastating plasmacytosis outbreaks following
inoculations with infected tissue suspensions used as autologous vaccinations against canine
distemper virus, it was realized that an infectious agent was responsible for the disease.
Unfortunately the virus had already been shipped worldwide with infected mink (Gorham et al.,
1965).
The ﬁrst scientiﬁc evidence of an infectious cause was the demonstration that suspensions of
infected mink organs retained their infectivity after ﬁltration, indicating the causative agent was
likely viral (Karstad and Pridham, 1962). The virus was subsequently isolated using feline kidney
cell lines and it was concluded that it possessed the distinctive properties of a parvovirus (Hahn
et al., 1977; Porter et al., 1977). The complete genome was sequenced in 1988 (Bloom et al.,
1988).
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Fifty years after the discovery of AMDV, three related viruses
have been identiﬁed in other mammals. AMDV is, however, the
best characterized virus in its genus and was the focus of the
majority of the literature considered.
CLASSIFICATION AND RELATIONSHIPS
AMONGST AMDOPARVOVIRUSES
Aleutian mink disease virus remained the sole member of
the genus Amdovirus within the family Parvoviridae, subfamily
Parvovirinae, for many years. It has now been reclassiﬁed as
Carnivore amdoparvovirus 1 within the genus Amdoparvovirus
(ICTVdb, 2014). This genus also contains the other recently
discovered Carnivore amdoparvovirus 2 (gray fox amdovirus,
GFAV; Li et al., 2011), the proposed Carnivore amdoparvovirus
3 (raccoon dog and fox amdoparvovirus, RFAV; Shao et al., 2014)
and the red fox fecal amdovirus (RFFAV; Bodewes et al., 2014),
whose genome has only been partially sequenced and therefore is
not yet assigned oﬃcial taxonomic status.
Phylogenetic analysis shows that RFAV is more closely related
to AMDV (∼76% amino acid identity for the non-structural
protein NS1) and occupies an intermediate position between
AMDV and GFAV (Figure 1). RFFAV is more closely related
to GFAV, with an identity of >80% (Bodewes et al., 2014; Shao
et al., 2014). All RAFVs belong to the same species and share
∼95% amino acid identity in NS1, while three distinct lineages
can be recognized within Carnivore amdoparvovirus 1: AMDV-1,
AMDV-2 (within-lineage NS1 identity of 90–94% and 97–99%,
respectively) and AMDV-3, which is only 82–84% identical to
other AMDVs and might represent a diﬀerent species (Bloom
et al., 1988; Gottschalck et al., 1991, 1994; Schuierer et al., 1997;
FIGURE 1 | Phylogenetic analysis and genome organization of amdoparvoviruses. Analysis based on partial NS1 amino acid sequences is shown in the
top-left and based on partial VP1/2 amino acid sequences is shown in the top-right. Species are indicated in italics and proposed species and partially characterized
members are not italicized. The three lineages identifiable within Carnivore amdoparvovirus 1 in the NS1 phylogeny, Aleutian mink disease virus (AMDV)-1 to 3, are
indicated. The unrooted trees were built with the Maximum Likelihood method (Felsenstein, 1981) using the best-fitting substitution model identified by modeltest
with MEGA6 (Tamura et al., 2013). The NS1 tree is based on alignment of 189 amino acids and the model JTT + G = 1.0973 while the VP1 tree is based on
alignment of 274 amino acids and the model JTT + G = 0.4273. Bootstrap values are shown as percentages based on 1000 iterations where support was >75%
and the distance bars show the number of substitutions per site. The genome map is shown on the bottom as the plus-sense strand, 5′–3′ , with a scale bar in kb.
Open reading frames (ORFs) are indicated in blue with the three ORF 1-encoded non-structural proteins, which share the same N-termini but possess unique
C-termini, and two ORF 2-encoded capsid proteins indicated in red. The position of the promoter (P3) and polyadenylation sites (pA) are indicated in purple and
green, respectively. The predicted structures of the terminal loops are indicated at the two extremities. The right-end terminal palindrome adopts a U-shape
configuration with one region of unpaired nucleotides (bubble) and the left-end terminus adopts a Y configuration with a longer arm and two unpaired regions.
Accession numbers used to build the NS tree: Aleutian mink disease virus (AMDV)-G, JN040434; ADV-UtahI, X77083; ADV United, X77085; AMDV-SL-3, X97629;
ADV-K, X77084; ADV-LN1, GU108231; ADV-LN2, GU108232; ADV-LN3, GU269892; RFAV HC-R, KJ396348; RFAV QA-RF, KJ396349; RFAV XQ-JLR, KJ396350;
RFAV HS-R, KJ396347; GFAV, JN202450; red fox fecal amdovirus (RFFAV), KF823809. Accession numbers of additional sequences used to build the VP1 tree:
AMDV-Utah1, AMU39015; AMDV-Pullman, U39014; AMDV-K, M63044; AMDV-TR, U39013; AMDV-LN-1, GU183264; AMDV-LN-2, GU183265; AMDV-M21,
DQ630722; AMDV-Rus17, KJ174164; AMDV-Bel2, KJ174161; AMDV-FarEast, DQ371395; ADV-Rus11, KJ174158; AMDV-Fin05/C8, GQ336866.
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Li et al., 2012). AMDVs of ferrets appear genetically distinct from
those identiﬁed in mink (Murakami et al., 2001). Some authors
suggest yet more species might exist that have not been sequenced
completely (Knuuttila et al., 2015; Persson et al., 2015). Analyses
based on the capsid protein sequences reveal diﬀerent clustering
within Carnivore amdoparvovirus 1, suggesting the existence of
chimeric genomes generated after recombination (Shackelton
et al., 2007; Christensen et al., 2011; Li et al., 2012). Clustering
on phylogenetic trees does not correlate with pathogenicity or
year of sampling but partial geographic grouping can be observed
(Knuuttila et al., 2009; Nituch et al., 2012).
VIRUS STRUCTURE AND PROTEIN
EXPRESSION
Aleutian mink disease virus is a naked, spherical virus of 22–
26 nm diameter (Shahrabadi and Cho, 1977; Bloom et al., 1980).
Its capsid is characterized by a T = 1 icosahedral symmetry
and is formed by two diﬀerent proteins, VP1 and VP2, in an
approximate 1:9 ratio for a total of 60 proteins that are capable of
self-assembly (Clemens et al., 1992; McKenna et al., 1999; Bloom
et al., 2001; Cotmore and Tattersall, 2014). The capsid contains a
single molecule of heterotelomeric single-stranded DNA ∼4.8 kb
in size (Bloom et al., 1988; Schuierer et al., 1997; Li et al., 2012).
Minus-sense strands are encapsidated in preference to plus-sense
strands (Best and Bloom, 2006; Cotmore and Tattersall, 2014).
As in other parvoviruses NS1 is probably covalently attached to
the 5′ end of the genome and is located on the outside of the
infectious particles (Cotmore and Tattersall, 1988, 1989; Huang
et al., 2014).
The monosense genome consists of two open reading frames
(ORFs), ﬂanked by untranslated regions (Figure 1). The left
ORF encodes the non-structural proteins NS1, NS2, and NS3,
and the right ORF encodes the capsid proteins VP1 and VP2
(Clemens et al., 1992; Qiu et al., 2006; Huang et al., 2014).
The presence of one or two smaller middle ORFs (MORFs) has
been reported for Carnivore amdoparvovirus 1 and 2 (Bloom
et al., 1988; Gottschalck et al., 1991, 1994; Li et al., 2011). Six
diﬀerent mRNAs are generated from a single pre-mRNA, which
is transcribed from a single promoter, by alternative splicing
and alternative polyadenylation, with two polyadenylation sites
present (Best and Bloom, 2006; Qiu et al., 2006; Huang et al.,
2014).
The major non-structural protein, NS1, possesses ATPase
and helicase activity and ATP- and DNA-binding domains. It
localizes to the nucleus and is crucial for viral replication with
roles in DNA replication, regulation of transcription, and capsid
assembly (Bloom et al., 1988; Christensen et al., 1995; Huang
et al., 2014). NS2 co-localizes in the nucleus whereas NS3,
produced at lower levels, has extra-nuclear localization. Both
proteins are crucial for viral replication (Huang et al., 2014). The
capsid protein VP1 contains the entire sequence of VP2, but is
∼40 amino acids longer on the N-terminal side. Both proteins
are targets of the immune response (Mori et al., 1991; Bloom
et al., 2001). Unlike other parvoviruses, VP1 does not contain
a phospholipase A2 (PLA2) domain that mediates virus transfer
across the endosomal bilayer during infection (Zádori et al., 2001;
Cotmore and Tattersall, 2014).
As in all parvoviruses, amdoparvoviruses possess palindromic
sequences at both genomic extremities (Figure 1). These fold
into hairpin structures and mediate viral DNA replication by
functioning as primers and allowing the attachment of host
polymerases, and they are also essential for packaging (Cotmore
and Tattersall, 2014). AMDV is deﬁned as heterotelomeric
because the left and right genomic termini diﬀer in both size
and sequence, and therefore in structure (Y- and U-shaped,
respectively; Bloom et al., 1988, 1990; Ranz et al., 1989; Willwand
and Kaaden, 1990).
VIRUS TROPISM AND REPLICATION
Similar to other parvoviruses, AMDV replication is
S-phase-dependent, requiring actively dividing cells to
produce new progeny (Cotmore and Tattersall, 1987,
2014; Oleksiewicz and Alexandersen, 1997). In adult mink
AMDV infects macrophages and viral entry is probably
mediated by cellular Fc receptors recognizing antibody-
covered viral particles (Mori et al., 1991; Kanno et al., 1993).
Antibodies against the virus enhance viral entry into cells,
a phenomenon called antibody-dependent enhancement
(ADE; Kanno et al., 1993; Dworak et al., 1997). In mink
kits the virus infects alveolar type II cells of the lungs and
causes cell death (Alexandersen et al., 1987; Park et al.,
2005).
The absence of a PLA2 domain in VP1 might reﬂect a
mechanism for viral release from endosomes diﬀerent from
other parvoviruses (Zádori et al., 2001). Parvovirus NS1 is a
cytotoxic protein that induces apoptosis (Hsu et al., 2004), an
essential phenomenon for productive AMDV infection. It has
been shown that cellular caspases, proteins required during
apoptosis (Lamkanﬁ et al., 2006), cleave NS1 at two diﬀerent
sites (Best et al., 2002, 2003) and the cleaved NS1 is actively
transported into the nucleus where genome replication, regulated
by NS proteins, occurs (Huang et al., 2014).
Parvoviruses replicate their genome by rolling hairpin
replication (RHR), a mechanism adapted from the rolling circle
replication used by some circular DNA viruses [reviewed in
(Berns, 1990)]. Replication starts when the host polymerase
binds to the 3′ terminal hairpin and the genome is converted into
double-stranded DNA. NS1 then initiates strand displacement
replication, which involves the folding and unfolding of a
single DNA molecule repeatedly rearranged into intermediate
replication forms (Berns, 1990). Although AMDV DNA
replication has not been completely studied, the identiﬁcation
of several replication intermediates is consistent with an RHR
model (Bloom et al., 1983; Löchelt et al., 1989). Finally, VP1
of AMDV is able to speciﬁcally bind viral DNA when folded
into a secondary intermediate replication structure, and this
binding seems to be responsible for the simultaneous segregation
and encapsidation of the single-stranded genomes into empty
capsids (Cotmore and Tattersall, 1987; Willwand and Kaaden,
1990).
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TRANSMISSION AND HOST RANGE
All bodily ﬂuids (blood, saliva, feces, and urine) can contain
viruses and transmission via direct or indirect (contaminated
feed, water, or environment) contacts are both possible (Kenyon
et al., 1963; Gorham et al., 1964; Pennick et al., 2005; Shao
et al., 2014). Virions are highly resistant in the environment
and can survive high temperatures and chemical treatments
(Eklund et al., 1968; Hahn et al., 1977; Porter et al., 1977). This
stability makes the virus diﬃcult to eliminate from contaminated
surfaces and facilitates viral spreading in the wild, and within
and between farms (Prieto et al., 2014). AMDV can also be
transmitted vertically from infected females to kits, with not
only trans-placental transmission possible but the placenta also
representing a site of viral replication (Broll and Alexandersen,
1996). Finally, a study demonstrated that the mosquito Aedes
ﬁtchii, which can feed onmink, can carry AMDV for up to 35 days
after an infectious blood meal, and the virus may replicate in
this vector indicating that vector-borne transmission may also be
possible (Shen et al., 1973).
Experimental infection and DNA detection studies showed
that AMDV can infect other mustelids besides mink (weasels,
badgers, ferrets, otters) and also other animals such as skunks,
raccoons, bobcats, cats, dogs, mice, and humans (Porter et al.,
1982; Alexandersen et al., 1985; Oie et al., 1996;Mañas et al., 2001;
Pennick et al., 2007; Allender et al., 2008; Jepsen et al., 2009; Farid,
2013; Knuuttila et al., 2015). Carnivore amdoparvovirus 2 has
been identiﬁed only in gray fox to date (Li et al., 2011), whereas
RFAV has been found in Arctic fox and raccoon dog (Shao et al.,
2014) and RFFAV has been found only in feces of wild red fox
(Bodewes et al., 2014).
EPIDEMIOLOGY
Aleutian mink disease virus aﬀects farmed and free-living
animals, where it propagates and evolves with diﬀerent dynamics.
Viruses identiﬁed in the two reservoirs and in diﬀerent locations
can be very similar, indicating exchange of strains between
the wild and farms, and amongst diﬀerent farms following the
movement of animals or contaminated materials. Accidental
escape or deliberate release of infected animals from farms, where
intensive farming facilitates disease spread, makes farms a source
of viruses for wild populations (Gunnarsson, 2001; Mañas et al.,
2001; Fournier-Chambrillon et al., 2004; Nituch et al., 2011,
2012).
The AMDV epidemic is thought to have originated in North
America, which is where mink farming began during the late
1800s. Even though the disease was ﬁrst described in farmed
animals, it is unknown if the virus ﬁrst emerged in the wild or
on farms (Hartsough and Gorham, 1956; Gorham et al., 1965;
Nituch et al., 2012). The only available AMDV epidemiological
data for North America come from Canada (Table 1). In Nova
Scotia the virus is highly prevalent in wild mink (up to 93% of
animals carry the virus or anti-amdoparvovirus antibodies) and
in other wild animals (Table 1). It is also prevalent on farms (up to
70% in 2003), but eﬀorts for implementing eradication strategies
are reducing the number of aﬀected animals (Farid et al., 2010,
2012; Farid, 2013). During the 1970s a study in Ontario reported
a 62% seroprevalence in wild animals and 46% of farms contained
seropositive animals (up to 85% per farm), while from 1986–2006
14–60% of farms tested positive and 25–38% of wild animals were
positive from 2005–2009 (Cho andGreenﬁeld, 1978; Nituch et al.,
2011, 2012).
TABLE 1 | Amdoparvovirus epidemiology in wild and farmed animals.
Geographical area Origin∗ Species§ Prevalence (%)& Detection method£ Period Study
Aleutian mink disease virus (AMDV)
Nova Scotia, Canada W American mink 78.6 PCR 2006–2008 Farid et al., 2010
W American mink 93.3 CIEP, PCR 2009–2011 Farid, 2013
W Ermine 70.5
W Striped skunk 25
W Northern river otter 18.2
W Northern raccoon 10.6
W Bobcat 10
F American mink 23.8–70.7 CIEP 1998–2005 Farid et al., 2012
Ontario, Canada W Mink sp. 61.2 CIEP Early 1970s Cho and Greenfield, 1978
W Mink sp. 29–38 CIEP 2005–2009 Nituch et al., 2011
W Mink sp. 25 PCR 2005–2009 Nituch et al., 2012
F Mink sp. 46.3 CIEP 1970s Cho and Greenfield, 1978
F Mink sp. 14–60 / 1986–2006 Nituch et al., 2012
USA F Mink sp. / PCR 1990s Hadlow et al., 1983
F Mink sp. / PCR 1990s Oie et al., 1996
Spain W European mink 33 CIEP, PCR 1997–1999 Mañas et al., 2001
W American mink 40 PCR
W Eurasian otter 100$ PCR
UK W American mink 51.8 CIEP 2000 Yamaguchi and Macdonald, 2001
D Ferret 8.5 Serology 1993 Welchman et al., 1993
(Continued)
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TABLE 1 | Continued
Geographical area Origin∗ Species§ Prevalence (%)& Detection
method£
Period Study
France W American mink 22.7 CCIE,
CCLAIE
1991–2001 Fournier-Chambrillon
et al., 2004
W European mink 12.1
W European polecat 11
W Stone marten 23.5
W Pine marten 6.3
W Common genet 4.4
Denmark
Bornholm island W Mink sp. 45.1 CCIE, PCR 1998–2009 Jensen et al., 2012
Mainland W Mink sp. 3.3 CCIE
F Mink sp. 5 / 2001 Christensen et al., 2011
Sweden W Mink sp. 46,58 2004–2009 Persson et al., 2015
F Mink sp. / / 2000s Persson et al., 2015
Finland W American mink 54.4 ELISA, PCR 2006–2014 Knuuttila et al., 2015
W European badger 26.9
W European polecat 7.1
F Mink sp. 3–60# CIEP 1980–2014 Knuuttila et al., 2015
Estonia W American mink 14.8 PCR 2007–2010 Leimann et al., 2015
Ireland F Mink sp. 80 PCR 2006 Jahns et al., 2010
Iceland W Mink sp. 3.6 CCE 1980s
F Mink sp. / CCE 1996 Gunnarsson, 2001
The Netherlands F Mink sp. / PCR 2005 Christensen et al., 2011
Germany F Mink sp. / PCR
ISH + SB
1980s Schuierer et al., 1997
Haas et al., 1988
China F Mink sp. / / 2009 Li et al., 2012
Russia F Mink sp. / PCR 2000s Martynenko and
Bogunov, 2007
Red fox fecal amdovirus (RFFAV)
Spain W Red fox / Metagenomics 2013 Bodewes et al., 2014
Gray fox amdovirus (GFAV)
California F Gray fox / PCR 2009 Li et al., 2011
Raccoon dog and fox amdoparvovirus (RFAV)
China F Arctic fox / PCR 2012–2013 Shao et al., 2014
F Raccoon dog / PCR 2012–2013
∗F, farm; W, wild; D, domestic.
§ American mink, Neovison vison; European mink, Mustela lutreola; ermine, Mustela erminea; striped skunk, Mephitis mephitis; northern river otter, Lontra canadensis;
northern raccoon, Procyon lotor; bobcat, Lynx rufus; Eurasian otter, Lutra lutra; European polecat, Mustela putorius; stone marten, Martes foina; pine marten,
Martes martes; common genet, Genetta genetta; European badger, Meles meles; ferret, Mustela putorius; mink sp., species not specified in the study; red fox,
Vulpes vulpes; gray fox, Urocyon cinereoargenteus; Arctic fox, Vulpes lagopus; raccoon dog, Nyctereutes procyonoides.
&Unless otherwise indicated values refer to the prevalence of infected wild animals for W or percentage of affected farms for F. A / indicates that the data is unknown.
£PCR, polymerase chain reaction; CIEP, counter immunoelectrophoresis; CCIE, counter-current immunoelectrophoresis; CCLAIE, counter-current line absorption
immunoelectrophoresis; CCE, counter current electrophoresis; ISH, in situ hybridization; SB, Southern blot. A / indicates that the data is unknown.
$Only one individual tested.
#Annual mean seroprevalence of farmed mink.
Americanmink were introduced into Europe during the 1920s
and 1930s for farming purposes (Macdonald and Harrington,
2003), and this is probably how AMDV was introduced
there (Mañas et al., 2001; Fournier-Chambrillon et al., 2004;
Knuuttila et al., 2009). Evidence of infection has been found
in various free-ranging animals in diﬀerent European countries
(Table 1).
Aleutian mink disease virus is also present in European
farms (Table 1). Between 1980 and 2014 the seroprevalence in
Finnish farms ﬂuctuated between 3 and 60%, a recent report
indicates that 80% of farms in Ireland have Aleutian disease,
and the virus was also reported in German and Dutch farms
(Haas et al., 1988; Jahns et al., 2010; Knuuttila et al., 2015). In
Denmark, eradication strategies were implemented in 1999 and
only 5% of farms were Aleutian disease-positive as of 2001. In
Iceland, eradication of the virus was achieved after infection
rates up to 90% on aﬀected farms were reported during the
1970s, but the virus was re-introduced during the late 1990s
(Skírnisson et al., 1990; Gunnarsson, 2001; Christensen et al.,
2011). A serological investigation also demonstrated that 8.5%
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of domestic ferrets owned by members of a ferret club were
amdoparvovirus antibody-positive (Welchman et al., 1993).
Mink were exported to eastern Europe and Asia between the
1930 and 1960s from Finland, Denmark, and North America
and the presence of the virus has been reported in Russia
and in China, where the seroprevalence was 43–67% in 2010
(Macdonald and Harrington, 2003; Martynenko and Bogunov,
2007; Knuuttila et al., 2009; Li et al., 2012).
Our understanding of the epidemiology of the other
amdoparvoviruses is much more limited (Table 1). RFAV was
identiﬁed in six farms in China, RFFAV in wild foxes in the
Spanish Basque region, and GFAV in two animals in California
(Li et al., 2011; Bodewes et al., 2014; Shao et al., 2014).
CLINICAL SIGNS AND PATHOGENESIS
Infection of mink by AMDV manifests in diﬀerent ways
depending on the age of the mink, with diﬀerent pathology
and cell-tropism in kits versus adults. In adults, the virus
causes a persistent infection that leads to a progressive
wasting syndrome, characterized by weight loss and anorexia
associated with splenomegaly, lymphadenopathy, plasmacytosis,
hypergammaglobulinemia, necrotizing arteritis, and proliferative
glomerulonephritis (Eklund et al., 1968; Hadlow et al., 1984). The
plasmacytosis leads to a massive production of antibodies, which
then enhances viral production (Kanno et al., 1993; Dworak et al.,
1997) and causes the formation of perivascular and glomerular
virus-antibody complexes that deposit in tissues leading to
arteritis and glomerulonephritis (Cho and Ingram, 1973; Porter
et al., 1973). The role of immunocomplexes in the pathogenesis
of AMDV is conﬁrmed by the fact that immunosuppressed
mink do not develop lesions when infected (Cheema et al.,
1972) and is the reason for vaccination failure (Aasted et al.,
1998), although promising results have been obtained with NS1
DNA vaccination (Castelruiz et al., 2005). Finally, the infection
reduces pregnancy rates and is associated with decreased litter
size, embryonic death and abortion (Broll and Alexandersen,
1996).
In kits the virus causes an acute infection that manifests as
respiratory distress and fulminant interstitial pneumonia, which
is due to a direct cytopathic eﬀect in pneumocytes, and is
mostly fatal within 3 weeks post-infection (Alexandersen, 1986;
Alexandersen et al., 1987; Park et al., 2005). Treatment of kits with
anti-AMDV antibodies limits viremia, reduces both mortality
and severity, and is protective against acute pneumonia but not
against the chronic adult form of the disease (Alexandersen
et al., 1989). The transfer of maternal antibodies might therefore
prevent pneumonia after birth.
In ferrets and skunks, AMDV causes a similar wasting
syndrome with kidney impairment and glomerulonephritis
(Kenyon et al., 1967; Ohshima et al., 1978; Pennick et al.,
2007; Allender et al., 2008). A respiratory disease with severe
coughing that leads to hemorrhagic interstitial pneumonia has
also been reported in ferrets (Welchman et al., 1993). Neurologic
signs and uveitis can also appear in both ferrets and mink
and arteritis in the cardiac muscle has been described in
ferrets (Hadlow, 1982; Palley et al., 1992; Welchman et al.,
1993; Dyer et al., 2000). Human macrophages are susceptible
to AMDV infection (Kanno et al., 1993) but infections in
humans, clinically similar to the disease in mink, have only been
documented in farmers after occupational exposure (Chapman
and Jimenez, 1963; Jepsen et al., 2009). They are an exceptionally
rare event considering the large number of aﬀected farms and
mink.
Asymptomatic and non-persistent infections are common
in both mink and ferrets, and in these individuals a lower
antibody response and a transient viremia are observed (Larsen
and Porter, 1975; An et al., 1978; Hadlow et al., 1984; Pennick
et al., 2005). The mortality rate is much higher in mink
of the Aleutian genotype compared to non-Aleutian mink
(Gorham et al., 1965; Bloom et al., 1975), but the response
to infection does not seem genetically determined in mink
of the same type (Larsen and Porter, 1975; Hadlow et al.,
1983, 1984; Gottschalck et al., 1994). Disease severity also
depends on the viral strain. Highly pathogenic viruses cause
high mortality in kits and severe disease in all adults, low
virulence strains cause low mortality in kits and mild disease
in non-Aleutian adults while still causing a severe illness in
Aleutian mink, and some lab-adapted strains have lost their
pathogenicity (Hadlow et al., 1983; Alexandersen, 1986; Bloom
et al., 1988).
Clinical signs reported for RFAV included anorexia,
emaciation, growth retardation, thirst, chronic diarrhea,
splenomegaly, enlarged lymph nodes, renal cortex congestion,
and brittleness in raccoon dog and emaciation, growth
retardation, pale swollen kidneys, and severe diarrhea in Arctic
fox (Shao et al., 2014). Clinical signs reported for Carnivore
amdoparvovirus 2 in gray fox included gait abnormalities,
lymphadenopathy and acute muscle inﬂammation (Li
et al., 2011). Clinical manifestations of RFFAV infection are
unknown.
CONCLUDING REMARKS
Amdoparvoviruses cause severe diseases in a wide range of
animals, resulting in major economic losses for farmers and
threatening wild animal populations. Continued research
and an increased awareness of these scientiﬁcally and
clinically relevant animal viruses will provide a better
picture of their total impact as more information becomes
available in the coming years and will likely lead to
the discovery of additional new species and susceptible
hosts.
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